RESUMEN
OBJECTIVE: The aim of this study was to investigate the effects of transcranial direct current stimulation (TDCS) combined with tinnitus retraining therapy (TRT) on clinical efficacy and sleep disorder in patients with chronic tinnitus. PATIENTS AND METHODS: 126 patients with chronic tinnitus treated in our hospital from May 2020 to June 2022 were retrospectively analyzed. These subjects were randomly divided into two groups: the electrical stimulation group and the combined group, in line with the random table method, with 63 patients in each group. Patients in the electrical stimulation group received TDCS treatment, and patients in the combined group were given TDCS combined with TRT. The clinical effects, tinnitus severity [Tinnitus Evaluation Questionnaire (TEQ) score and Tinnitus handicap inventory (THI) score], sleep status [Sleep Status Rating Scale (SRSS) score and Pittsburgh Sleep Quality Index (PSQI) score], psychological status [Hamilton Anxiety Scale (HAMA) score and Self Rating Depression Scale (SDS) score] and the quality of life (Quality of Life Scale) of these subjects in two groups were analyzed. RESULTS: The clinical effect of simple TDCS was 82.53%, which was sharply lower compared to 95.24% in the combined group (p<0.05). After the treatment, TEQ score, THI score, SRSS score, PSQI score, HAMA score, and SDS score were decreased in both groups (p<0.05), and the combined group was much lower than the TDCS group (p<0.01). Compared with the pre-treatment period, the scores of restrictions in daily living, medical resource utilization, somatic symptoms, and emotional disturbance were elevated in both groups after treatment, and the combined group had markedly higher scores than the TDCS group (p<0.05). CONCLUSIONS: TDCS combined with TRT had obvious effects in treating chronic tinnitus, which largely reduced the severity of tinnitus, improved patients' sleep quality and psychological status, and improved the quality of life, indicating a certain worthy of clinical application and promotion.
Asunto(s)
Trastornos del Sueño-Vigilia , Acúfeno , Estimulación Transcraneal de Corriente Directa , Humanos , Calidad de Vida , Estudios Retrospectivos , Acúfeno/terapia , Trastornos del Sueño-Vigilia/terapiaRESUMEN
OBJECTIVE: In many cancers, long non-coding RNAs (lncRNA) are largely involved; they can regulate cell proliferation, migration, and invasion. However, the research of lncRNA regulation on pancreatic ductal adenocarcinoma is vacant. The aim of this article was to lucubrate the specific role of lncRNA LUCAT1 in regulating the progression of pancreatic cancer. PATIENTS AND METHODS: Pancreatic cancer and adjacent tissues were collected, and the expression of LUCAT1, one potential involved LucRNA, was measured using real-time qPCR (RT-qPCR). Different pathological types of pancreatic cancer cell lines were cultured, and the expression difference of LncRNA LUCAT1 was detected by RT-qPCR, and two cell lines were selected for downstream experiments. si-RNA was used to knockdown the expression of LUCAT1, comparing the difference in expression of LUCAT1, characterizing cell proliferation by MTT and BrdU staining, detecting apoptosis, and cell cycle changes by flow cytometry. Meanwhile, Western blotting was used for the detection of cyclin expression and thus investigate two important associated signaling pathways. Besides, the expression of signaling pathway was validated by signaling inhibitor. RESULTS: In comparison to normal cells, LUCAT1 was highly expressed in human pancreatic cancer cell lines (p<0.05). The higher expression of LUCAT1 resulted in enhanced pathogenesis of PDA cells and motivated the development to S phase by regulation of cyclin D1, CDK4. Furthermore, LUCAT1 promoted PDA cells development by inducing AKT's and p38 MAPK's phosphorylation. CONCLUSIONS: LUCAT1, as the key factor, played a positive role in the proliferation and invasion of pancreatic cells via AKT/MAPK signaling.
Asunto(s)
Neoplasias Pancreáticas/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , ARN Largo no Codificante/metabolismo , Proliferación Celular , Humanos , Neoplasias Pancreáticas/patología , Fosforilación , ARN Largo no Codificante/genética , Células Tumorales CultivadasRESUMEN
OBJECTIVE: As the contamination of implant surface seriously affects the early osseointegration of implants and reduces the survival rate of implants, it has attracted wide attention of researchers. The most oral titanium implants used in current clinical applications are stored in sealed packages. During the process of packaging, storage and usage, the implants inevitably contact air, which results in the surface contamination. As an inert gas, the argon has very inactive chemical properties and is routinely used as a protective gas to cut air pollution. In this study, we investigated whether argon protection can cut air pollution and maintain lasting surface biological activity of titanium implants. MATERIALS AND METHODS: We prepared sandblasting etched titanium samples under air protection or under argon protection. The samples prepared under air protection were used as the control. With the scanning electron microscopy, the contact angle measurements and the X-ray photoelectron spectroscopy, we examined surface morphology, hydrophilicity, chemical structures and components of the implants prepared under two gas protections. By using beagles as the animal model, we assessed the bone guide of the implants prepared under argon protection and morphological changes of surrounding tissues. RESULTS: While compared with those implants prepared under air protection, the surface morphology of implants prepared under argon protection did not change, which had preferable hydrophilicity, and there were differences in percentage of surface chemical elements and chemical structure. After 4 weeks, the bone-implant contact (BIC) in argon protection group was twice of the control group and the difference was statistically significant (p < 0.01). The Implant Niuchu experiments also proved that under argon protection, the implants would have good integration with the surrounding bone tissues. CONCLUSIONS: This study revealed the implants prepared under argon can cut air pollution and have high bone guide property and biological activity.
Asunto(s)
Argón/química , Interfase Hueso-Implante , Prótesis e Implantes , Titanio/química , Contaminantes Atmosféricos/análisis , Animales , Materiales Biocompatibles/química , Perros , Masculino , Microscopía Electrónica de Rastreo , Oseointegración , Propiedades de Superficie , TibiaRESUMEN
Wolbachia is an intracellular bacterium that has aroused intense interest because of its ability to alter the biology of its host in diverse ways. In the two-spotted spider mite, Tetranychus urticae, Wolbachia can induce complex cytoplasmic incompatibility (CI) phenotypes and fitness changes, although little is known about the mechanisms. In the present study, we selected a strain of T. urticae, in which Wolbachia infection was associated with strong CI and enhanced female fecundity, to investigate changes in the transcriptome of T. urticae in Wolbachia-infected vs. uninfected lines. The responses were found to be sex-specific, with the transcription of 251 genes being affected in females and 171 genes being affected in males. Some of the more profoundly affected genes in both sexes were lipocalin genes and genes involved in oxidation reduction, digestion and detoxification. Several of the differentially expressed genes have potential roles in reproduction. Interestingly, unlike certain Wolbachia transinfections in novel hosts, the Wolbachia-host association in the present study showed no clear evidence of host immune priming by Wolbachia, although a few potential immune genes were affected.
Asunto(s)
Tetranychidae/genética , Tetranychidae/microbiología , Wolbachia/fisiología , Animales , Citoplasma/fisiología , Femenino , Perfilación de la Expresión Génica , Masculino , Oxidación-Reducción , Fenotipo , Reacción en Cadena en Tiempo Real de la Polimerasa , Reproducción/genética , Simbiosis/genética , Tetranychidae/inmunología , TranscriptomaRESUMEN
Under normal conditions, progesterone inhi-bits the estrogen-induced proliferation of endometrial epithelium. Our previous studies have shown that cyclin G1 was progesterone-dependent in mouse endometrial epithelium at peri-implantation, and exogenous cyclin G1 suppressed the proliferation of endometrial cancer cells. The objectives of this study are to determine whether cyclin G1, as a negative regulator of the cell cycle, is involved in the antiproliferative action of progesterone on endometrial epithelial cells, and to explore the possible molecular mechanism of cyclin G1 inhibition. The siRNA-mediated elimination of cyclin G1 attenuated the antiproliferative action of progesterone on endometrial epithelial cells. Immunoprecipitation showed that progesterone-induced cyclin G1 could interact with PP2A to mediate its phosphatase activity. The block of PP2A activity also attenuated the antiproliferative action of progesterone on endometrial epithelial cells and increased the phosphorylated Rb. In conclusion, progesterone-induced cyclin G1 mediates the inhibitory effect of progesterone on endometrial epithelial cell proliferation possibly through the recruitment of PP2A to dephosphorylate Rb.
Asunto(s)
Ciclina G1/metabolismo , Endometrio/citología , Células Epiteliales/metabolismo , Progesterona/farmacología , Animales , Proliferación Celular/efectos de los fármacos , Células Epiteliales/citología , Células Epiteliales/efectos de los fármacos , Femenino , Humanos , Ratones , Ácido Ocadaico/farmacología , Unión Proteica/efectos de los fármacos , Proteína Fosfatasa 2/metabolismo , ARN Interferente Pequeño/metabolismoRESUMEN
AIMS: To construct novel brewer's yeast strains with the ability to degrade beta-glucan and increase sulfite levels in beer brewing by genetic manipulation. METHODS AND RESULTS: The recombinant plasmid pA15ME containing P(met10)-egl1-T(met10) expression cassette was constructed. BamHI-linearized target plasmid pA15ME was transformed into the industrial brewer's yeast strain Z0103 to replace the MET10 locus through one-step gene replacement. The recombinants Z8, Z7 and Z3 with the ability to secrete active endo-beta-1,4-glucanase I into the culture medium were isolated by Congo red dyeing. The enzymatic activities of EG I of Z8, Z7 and Z3 were 3.3, 1.5, 1.3 U l(-1), and the hydrolysing degrees of beta-glucans in wort were increased 11.9%, 8.6% and 6.9%, respectively, than that of original strain Z0103. The MET10 gene deletions were confirmed by real-time PCR, and the sulfite levels of the culture mediums inoculated with Z8, Z7 and Z3 were increased 26%, 16% and 17%, respectively, compared to that of Z0103. CONCLUSIONS: The novel endoglucanase-producing brewer's yeast strains with inserted endoglucanase gene and deficient MET10 gene led to reduced content of barley beta-glucans, enhanced filterability and increased sulfur dioxide in fermenting wort. Thus, the cost for addition of microbial beta-glucanase enzyme and sulfite preparations in normal beer brewing processes could be reduced. SIGNIFICANCE AND IMPACT OF THE STUDY: These results suggested that genetic engineering approach is a powerful tool to construct the novel recombinant brewer's yeast strains with different properties to reduce the cost of beer brewing and improve the flavour of a beer, and the strains obtained have potential application value in beer brewing.